• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖纳米制剂的设计与特性研究及其作为抗真菌药物载体的应用。

Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents.

机构信息

Instituto de Química Rosario (IQUIR, CONICET-UNR), Suipacha 531, Rosario S2002LRK, Argentina.

Área Análisis de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, Rosario S2002LRK, Argentina.

出版信息

Int J Mol Sci. 2019 Jul 27;20(15):3686. doi: 10.3390/ijms20153686.

DOI:10.3390/ijms20153686
PMID:31357647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6695956/
Abstract

Among different Candida species triggering vaginal candidiasis, is the most predominant yeast. It is commonly treated using azole drugs such as Tioconazole (TIO) and Econazole (ECO). However, their low water solubility may affect their therapeutic efficiency. Therefore, the aim of this research was to produce a novel chitosan nanocapsule based delivery system comprising of TIO or ECO and to study their suitability in vaginal application. These systems were characterized by their physicochemical properties, encapsulation efficiency, in vitro release, storage stability, cytotoxicity, and in vitro biological activity. Both nanocapsules loaded with TIO (average hydrodynamic size of 146.8 ± 0.8 nm, zeta potential of +24.7 ± 1.1 mV) or ECO (average hydrodynamic size of 127.1 ± 1.5 nm, zeta potential of +33.0 ± 1.0 mV) showed excellent association efficiency (99% for TIO and 87% for ECO). The analysis of size, polydispersity index, and zeta potential of the systems at 4, 25, and 37 °C (over a period of two months) showed the stability of the systems. Finally, the developed nanosystems presented fungicidal activity against at non-toxic concentrations (studied on model human skin cells). The results obtained from this study are the first step in the development of a pharmaceutical dosage form suitable for the treatment of vaginal candidiasis.

摘要

在引发阴道念珠菌病的不同念珠菌物种中,白色念珠菌是最主要的酵母。它通常用唑类药物治疗,如噻康唑(TIO)和益康唑(ECO)。然而,它们的低水溶性可能会影响它们的治疗效果。因此,本研究的目的是制备一种新型的壳聚糖纳米胶囊给药系统,包含 TIO 或 ECO,并研究其在阴道应用中的适用性。这些系统的特点是其物理化学性质、包封效率、体外释放、储存稳定性、细胞毒性和体外生物活性。载有 TIO(平均水动力粒径为 146.8 ± 0.8nm,zeta 电位为+24.7 ± 1.1mV)或 ECO(平均水动力粒径为 127.1 ± 1.5nm,zeta 电位为+33.0 ± 1.0mV)的纳米胶囊均表现出优异的结合效率(TIO 为 99%,ECO 为 87%)。在 4、25 和 37°C 下(两个月内)对系统的粒径、多分散指数和 zeta 电位进行分析,表明系统的稳定性。最后,开发的纳米系统在非毒性浓度下对白色念珠菌表现出杀菌活性(在模型人皮肤细胞上进行研究)。本研究的结果是开发适合阴道念珠菌病治疗的药物剂型的第一步。

相似文献

1
Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents.壳聚糖纳米制剂的设计与特性研究及其作为抗真菌药物载体的应用。
Int J Mol Sci. 2019 Jul 27;20(15):3686. doi: 10.3390/ijms20153686.
2
Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment.用于透皮给药的硝酸益康唑传递体:研制、体外特性及离体评估
Pharm Nanotechnol. 2018;6(3):171-179. doi: 10.2174/2211738506666180813122102.
3
Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.壳聚糖/磺丁醚-β-环糊精纳米粒作为眼部药物传递的一种有潜力的方法。
Int J Pharm. 2011 Jul 15;413(1-2):229-36. doi: 10.1016/j.ijpharm.2011.04.031. Epub 2011 Apr 21.
4
Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis.壳聚糖-羟丙基甲基纤维素替硝唑薄膜:治疗阴道念珠菌病的有前途的替代剂型。
Int J Pharm. 2019 Feb 10;556:181-191. doi: 10.1016/j.ijpharm.2018.12.011. Epub 2018 Dec 12.
5
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.壳聚糖基纳米递药系统在新型三氯苯达唑制剂开发中的应用。
PLoS One. 2018 Dec 12;13(12):e0207625. doi: 10.1371/journal.pone.0207625. eCollection 2018.
6
Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole.椰油核阳离子纳米胶囊的制备及其体外评价用于克霉唑阴道给药
Colloids Surf B Biointerfaces. 2014 Apr 1;116:270-6. doi: 10.1016/j.colsurfb.2014.01.011. Epub 2014 Jan 19.
7
Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.壳聚糖功能化聚(ε-己内酯)纳米粒用于两性霉素 B 的递送。
Carbohydr Polym. 2018 Dec 15;202:345-354. doi: 10.1016/j.carbpol.2018.08.142. Epub 2018 Sep 5.
8
A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation.一种含尤特奇RS微粒的壳聚糖乳酸盐/泊洛沙姆407基基质用于益康唑的阴道给药:设计与体外评价
Drug Dev Ind Pharm. 2013 Dec;39(12):1911-20. doi: 10.3109/03639045.2012.694589. Epub 2012 Jun 8.
9
An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment.一种用于改善甲癣治疗的基于多糖纳米颗粒的创新型指甲制剂。
Eur J Pharm Sci. 2017 Mar 30;100:56-63. doi: 10.1016/j.ejps.2016.12.043. Epub 2017 Jan 5.
10
Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate.通过喷雾冷凝法制备的基于聚合物-脂质的硝酸益康唑阴道给药粘膜粘附微球。
Eur J Pharm Sci. 2009 Mar 2;36(4-5):591-601. doi: 10.1016/j.ejps.2008.12.009. Epub 2008 Dec 25.

引用本文的文献

1
Reactive Oxygen Species-Responsive Ferrocene Nanoparticles Delivering Small Interfering RNA Targeting NOP2/Sun RNA Methyltransferase Family Member 2 for Gastric Cancer Therapy.用于胃癌治疗的活性氧响应型二茂铁纳米颗粒递送靶向NOP2/Sun RNA甲基转移酶家族成员2的小干扰RNA
Biomater Res. 2024 May 29;29:0209. doi: 10.34133/bmr.0209. eCollection 2025.
2
Hydrogel- and Nanocomposite-Based Drug-Delivery Strategies in the Treatment of Vaginal Infections.基于水凝胶和纳米复合材料的药物递送策略在阴道感染治疗中的应用
Polymers (Basel). 2024 Mar 12;16(6):775. doi: 10.3390/polym16060775.
3
Molecular association of and vulvovaginal candidiasis: focusing on a solution.

本文引用的文献

1
Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release.基于纳米结构壳聚糖的生物材料用于持续和结肠特异性白藜芦醇释放。
Int J Mol Sci. 2019 Jan 18;20(2):398. doi: 10.3390/ijms20020398.
2
Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis.壳聚糖-羟丙基甲基纤维素替硝唑薄膜:治疗阴道念珠菌病的有前途的替代剂型。
Int J Pharm. 2019 Feb 10;556:181-191. doi: 10.1016/j.ijpharm.2018.12.011. Epub 2018 Dec 12.
3
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.
和外阴阴道念珠菌病的分子关联:聚焦于解决方案。
Front Cell Infect Microbiol. 2023 Oct 13;13:1245808. doi: 10.3389/fcimb.2023.1245808. eCollection 2023.
4
Emerging Polymer-Based Nanosystem Strategies in the Delivery of Antifungal Drugs.基于聚合物的新型纳米系统在抗真菌药物递送中的策略
Pharmaceutics. 2023 Jul 1;15(7):1866. doi: 10.3390/pharmaceutics15071866.
5
Nanoparticles: Taking a Unique Position in Medicine.纳米颗粒:在医学领域占据独特地位。
Nanomaterials (Basel). 2023 Jan 31;13(3):574. doi: 10.3390/nano13030574.
6
Synergistic Antimicrobial Activities of Chitosan Mixtures and Chitosan-Copper Combinations.壳聚糖混合物和壳聚糖-铜组合的协同抗菌活性。
Int J Mol Sci. 2022 Mar 20;23(6):3345. doi: 10.3390/ijms23063345.
7
The Expanded Role of Chitosan in Localized Antimicrobial Therapy.壳聚糖在局部抗菌治疗中的扩展作用。
Mar Drugs. 2021 Dec 8;19(12):697. doi: 10.3390/md19120697.
8
Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.抗击真菌感染:纳米系统在抗真菌策略中的应用。
Int J Mol Sci. 2021 Sep 18;22(18):10104. doi: 10.3390/ijms221810104.
9
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.壳聚糖纳米颗粒作为纳米医学中一种有前景的工具,尤其侧重于肿瘤治疗。
Cancer Cell Int. 2021 Jun 24;21(1):318. doi: 10.1186/s12935-021-02025-4.
10
Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials.纳米系统及抗菌药物阴道给药策略的最新进展
Nanomaterials (Basel). 2021 Jan 26;11(2):311. doi: 10.3390/nano11020311.
壳聚糖基纳米递药系统在新型三氯苯达唑制剂开发中的应用。
PLoS One. 2018 Dec 12;13(12):e0207625. doi: 10.1371/journal.pone.0207625. eCollection 2018.
4
A review on chitosan and its nanocomposites in drug delivery.壳聚糖及其纳米复合材料在药物传递中的研究进展综述。
Int J Biol Macromol. 2018 Apr 1;109:273-286. doi: 10.1016/j.ijbiomac.2017.12.078. Epub 2017 Dec 14.
5
Tretinoin-loaded lipid-core nanocapsules overcome the triple-negative breast cancer cell resistance to tretinoin and show synergistic effect on cytotoxicity induced by doxorubicin and 5-fluororacil.载维甲酸的脂芯纳米囊克服三阴性乳腺癌细胞对维甲酸的耐药性,并对阿霉素和 5-氟尿嘧啶诱导的细胞毒性表现出协同作用。
Biomed Pharmacother. 2017 Dec;96:404-409. doi: 10.1016/j.biopha.2017.10.020. Epub 2017 Oct 12.
6
Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.载有替诺福韦的纳米颗粒薄膜作为新型阴道杀微生物剂递送系统的研发及体内安全性评估。
Acta Biomater. 2016 Oct 15;44:332-40. doi: 10.1016/j.actbio.2016.08.018. Epub 2016 Aug 17.
7
Why Chitosan? From properties to perspective of mucosal drug delivery.为什么是壳聚糖?从特性到黏膜给药的前景。
Int J Biol Macromol. 2016 Oct;91:615-22. doi: 10.1016/j.ijbiomac.2016.05.054. Epub 2016 May 16.
8
Spray-dried powders improve the controlled release of antifungal tioconazole-loaded polymeric nanocapsules compared to with lyophilized products.喷雾干燥粉末比冷冻干燥产品更能改善载有抗真菌药物噻康唑的聚合物纳米胶囊的控制释放。
Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:875-884. doi: 10.1016/j.msec.2015.10.035. Epub 2015 Oct 23.
9
Novel drug delivery strategies for improving econazole antifungal action.新型药物递送策略提高克霉唑抗真菌作用。
Int J Pharm. 2015 Nov 10;495(1):599-607. doi: 10.1016/j.ijpharm.2015.09.015. Epub 2015 Sep 14.
10
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.联合抗半乳糖凝集素-1和抗表皮生长因子受体小干扰RNA的壳聚糖-脂质纳米胶囊降低胶质母细胞瘤对替莫唑胺的耐药性:体内评估
Int J Pharm. 2015 Mar 15;481(1-2):154-61. doi: 10.1016/j.ijpharm.2015.01.051. Epub 2015 Jan 30.